Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03600662

TriRec - Trileaflet Reconstruction of the Aortic Valve With Autologous Pericardium

TriRec - Trileaflet Reconstruction of the Aortic Valve

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
128 (estimated)
Sponsor
Deutsches Herzzentrum Muenchen · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

Reconstruction of the aortic valve using the tri-leaflet repair technique is non-inferior with regard to effective orifice area (EOA) to surgical aortic valve replacement (SAVR) with a biological prosthesis (St. Jude Trifecta GT) as gold- standard.

Conditions

Interventions

TypeNameDescription
OTHERTriRecTrileaflet Reconstruction of the Aortic Valve
OTHERAortic valve replacementBiological Prosthesis, Device: St. Jude Medical Trifecta GT

Timeline

Start date
2018-01-18
Primary completion
2020-01-01
Completion
2030-01-01
First posted
2018-07-26
Last updated
2018-07-26

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03600662. Inclusion in this directory is not an endorsement.